| 2024-10-13 | Myasthenia gravis - Drugs | 0:00 | 0 | |
|
| 2024-10-13 | Nicotinic receptors | 0:00 | 1 | |
|
| 2024-10-13 | Enzymatic receptors | 0:00 | 2 | |
|
| 2024-10-13 | Cor pulmonale - causes | 0:00 | 0 | |
|
| 2024-10-13 | Heart block types | 0:00 | 0 | |
|
| 2024-10-13 | AR management | 0:00 | 0 | |
|
| 2024-10-13 | Ligand gated ion channels | 0:00 | 2 | |
|
| 2024-10-13 | Anti Diarrhea drugs - part 3 | 0:00 | 0 | |
|
| 2024-10-13 | BPH - Benign prostatic hyperplasia treatment | 0:00 | 1 | |
|
| 2024-10-13 | Nuclear receptors | 0:00 | 0 | |
|
| 2024-10-13 | Aortic stenosis grading | 0:00 | 0 | |
|
| 2024-10-13 | CHA2DS2 - VASC scoring for risk of stroke and oral anti coagulation need in AF | 0:00 | 0 | |
|
| 2024-10-13 | VT vs SVT with aberrancy | 0:00 | 0 | |
|
| 2024-10-13 | Muscarinic receptors | 0:00 | 1 | |
|
| 2024-10-13 | Parasympathetic nervous system | 0:00 | 0 | |
|
| 2024-10-13 | Wilsons disease - Classic presentation | 0:00 | 1 | |
|
| 2024-10-13 | Human teratogenic drugs | 0:00 | 0 | |
|
| 2024-10-13 | Pneumothorax - Types and management | 0:00 | 0 | |
|
| 2024-10-13 | Beta blockers types | 0:00 | 0 | |
|
| 2024-10-13 | Henoch schonlein purpura HSP - Clinical features | 0:00 | 5 | |
|
| 2024-10-13 | Valvular heart disease causes | 0:00 | 1 | |
|
| 2024-10-13 | PSVT treatment - Paroxysmal supraventricular tachycardia | 0:00 | 1 | |
|
| 2024-10-13 | Pulmonary hypertension classification and causes | 0:00 | 1 | |
|
| 2024-10-13 | Alpha 1 receptor | 0:00 | 0 | |
|
| 2024-10-13 | Benign prostatic hyperplasia - BPH Surgical management | 0:00 | 0 | |
|
| 2024-10-13 | Holosytolic murmur - causes | 0:00 | 0 | |
|
| 2024-10-13 | Mitral regurgitation | 0:00 | 0 | |
|
| 2024-10-13 | Anti obesity drugs - part 2 | 0:00 | 1 | |
|
| 2024-10-13 | Alpha 2 receptors | 0:00 | 0 | |
|
| 2024-10-13 | Botulinum toxin | 0:00 | 0 | |
|
| 2024-10-13 | Hypertension management - AHA guidelines American heart association | 0:00 | 0 | |
|
| 2024-10-13 | Torsade de pointes - Etiology | 0:00 | 0 | |
|
| 2024-10-13 | Schedule of drugs | 0:00 | 0 | |
|
| 2024-10-13 | Sympathetic nervous system | 0:00 | 0 | |
|
| 2024-10-12 | Shock - Stages | 0:00 | 0 | |
|
| 2024-10-12 | 5HT3 receptor | 0:00 | 0 | |
|
| 2024-10-12 | Seizures and types | 0:00 | 2 | |
|
| 2024-10-12 | COPD - Chronic obstructive pulmonary disease | 0:00 | 0 | |
|
| 2024-10-12 | Pulmonary embolism | 0:00 | 0 | |
|
| 2024-10-12 | Haemolytic anemia | 0:00 | 1 | |
|
| 2024-10-12 | Anti diuretics | 0:00 | 2 | |
|
| 2024-10-12 | 5HT2 receptor | 0:00 | 1 | |
|
| 2024-10-12 | Hypertension - Causes | 0:00 | 0 | |
|
| 2024-10-12 | COPD vs Asthma | 0:00 | 0 | |
|
| 2024-10-12 | 5HT 1 receptor | 0:00 | 1 | |
|
| 2024-10-12 | Thyroid storm | 0:00 | 0 | |
|
| 2024-10-11 | Cardiac tamponade | 0:00 | 1 | |
|
| 2024-10-10 | Heart block - types | 0:00 | 0 | |
|
| 2024-10-10 | Shock - Types | 0:00 | 0 | |
|
| 2024-10-10 | Brain death - Criteria | 0:00 | 1 | |
|
| 2024-10-10 | Diabetic ketoacidosis - Management | 0:00 | 0 | |
|
| 2024-10-09 | Hypercalcemia - Causes | 0:00 | 0 | |
|
| 2024-10-09 | Cushing triad - Symptoms | 0:00 | 1 | |
|
| 2024-10-09 | Anti anginal drugs - Mechanism | 0:00 | 1 | |
|
| 2024-10-09 | Pulmonary embolism - Signs and symptoms | 0:00 | 1 | |
|
| 2024-10-09 | Haemorrhage - Types | 0:00 | 0 | |
|
| 2024-10-09 | Acute coronary syndrome | 0:00 | 2 | |
|
| 2024-10-09 | Acute respiratory distress syndrome - Pathophysiology ARDS | 0:00 | 0 | |
|
| 2024-10-09 | Nephrotic syndrome - Features and management | 0:00 | 0 | |
|
| 2024-10-09 | Nitrates - Uses and adverse effects | 0:00 | 2 | |
|
| 2024-10-09 | Meningitis - Classic triad of symptoms | 0:00 | 0 | |
|
| 2024-10-08 | Atrial fibrillation - Management | 0:00 | 0 | |
|
| 2024-10-08 | Targets to block RAAS pathway | 0:00 | 0 | |
|
| 2024-10-08 | Addison disease - Features | 0:00 | 1 | |
|
| 2024-10-07 | Tardive dyskinesia - Pathogenesis | 0:00 | 0 | |
|
| 2024-10-07 | Antidepressants - Classification | 0:00 | 0 | |
|
| 2024-10-07 | Hypertension drugs - HTN Adverse effects | 0:00 | 1 | |
|
| 2024-10-07 | Vitamin B12 deficiency | 0:00 | 1 | |
|
| 2024-10-07 | Seizure , epilepsy drugs | 0:00 | 4 | |
|
| 2024-10-07 | PSI - Pneumonia severity index score | 0:00 | 4 | |
|
| 2024-10-07 | Stages of labor | 0:00 | 13 | |
|
| 2024-10-07 | Type 2 Diabetes mellitus - Pathophysiology | 0:00 | 2 | |
|
| 2024-10-07 | Management of STEMI ST elevation myocardial infarction MI | 0:00 | 4 | |
|
| 2024-10-07 | Glasgow coma scale - GCS scoring | 0:00 | 0 | |
|
| 2024-10-07 | Upper GI Bleeding - Causes ( gastrointestinal ) | 0:00 | 4 | |
|
| 2024-10-07 | Beta blockers | 0:00 | 5 | |
|
| 2024-10-07 | Extrapyramidal symptoms - EPS treatment | 0:00 | 0 | |
|
| 2024-10-06 | HCM - Hypertrophic cardiomyopathy | 0:59 | 2 | |
|
| 2024-10-06 | Acute CHF - Management | 0:00 | 5 | |
|
| 2024-10-06 | Gallstone disease | 0:00 | 1 | |
|
| 2024-10-06 | Chronic CHF - Management | 0:00 | 0 | |
|
| 2024-10-06 | Cushing syndrome | 0:00 | 3 | |
|
| 2024-10-06 | MAO inhibitors - Uses ( Monoamine oxidase inhibitors ) | 0:00 | 4 | |
|
| 2024-10-06 | Hypertension - HTN guidelines | 0:00 | 2 | |
|
| 2024-10-06 | Graves disease - Pathophysiology and symptoms | 0:00 | 8 | |
|
| 2024-10-06 | Hypokalemia - Causes | 0:00 | 3 | |
|
| 2024-10-06 | MAO inhibitors - Classification and mechanism | 0:00 | 6 | |
|
| 2024-10-06 | ABG arterial blood gas interpretation | 0:00 | 0 | |
|
| 2024-10-06 | Nociceptin receptor | 0:00 | 2 | |
|
| 2024-10-06 | Hyperkalemia - ECG changes and management | 0:00 | 15 | |
|
| 2024-10-06 | Mallory Weiss tear - Causes and presentation | 0:00 | 11 | |
|
| 2024-10-06 | Lichen planus - Characteristic lesions | 0:00 | 2 | |
|
| 2024-10-06 | Multiple myeloma - Diagnostic criteria | 0:00 | 11 | |
|
| 2024-10-06 | Creutzfeldt Jakob disease | 0:00 | 6 | |
|
| 2024-10-06 | Nitrates - Mechanism of action and drugs | 0:00 | 3 | |
|
| 2024-10-06 | Acute appendicitis - Signs | 0:00 | 2 | |
|
| 2024-10-06 | Lung cancer types | 0:00 | 1 | |
|
| 2024-10-06 | Bronchiolitis - Common cause in infants | 0:00 | 13 | |
|
| 2024-10-06 | Parkinsons disease | 0:00 | 1 | |
|
| 2024-10-06 | Mu Opiod receptor | 0:00 | 6 | |
|
